インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • アカデミックキー
  • ジャーナル目次
  • 中国国家知識基盤 (CNKI)
  • ウルリッヒの定期刊行物ディレクトリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • 雑誌の抄録索引作成ディレクトリ
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • Google スカラー
このページをシェアする
ジャーナルチラシ
Flyer image

概要

A Review of the Placenta and Trophoblast Induced Pluripotent Stem Cells in Autism Spectrum Disorder Research

Sona Jasani*, Grace Tartaglia, Percy Luk Yeung and Chi-Wei Lu

Autism spectrum disorder (ASD) imparts a tremendous health burden with psychological, social, and economic implications. The biology of ASD is complex involving genetic, molecular, hormonal and immunologic factors however the convergence point of these various factors has not been identified as of yet. Limited evidence exists to suggest that the placenta may play such a governing role in ASD manifestation. The placenta is a neuroendocrine modulator by participating in the fetal hypothalamic pituitary gonadal (HPG) axis and also regulates the intrauterine environment mitigating fetal exposure to damaging factors to modulate the fetal stress response. Placental dysfunction has been associated with developmental abnormality and neuropsychiatric pathology adding to the biologic plausibility of the governing role the placenta may play in ASD development. By using current technology like induced pluripotent stem cells (iPSCs), a practical model system can be created to study ASD providing an alternative method to further research the placenta in ASD development